Lovastatin and Impaired gastric emptying - a phase IV clinical study of FDA data

Summary:

Impaired gastric emptying is found among people who take Lovastatin, especially for people who are female, 50-59 old.

The phase IV clinical study analyzes which people take Lovastatin and have Impaired gastric emptying. It is created by eHealthMe based on reports of 29,874 people who have side effects when taking Lovastatin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

29,874 people reported to have side effects when taking Lovastatin.
Among them, 31 people (0.1%) have Impaired gastric emptying.

What is Lovastatin?

Lovastatin has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 31,004 Lovastatin users for its effectiveness, alternative drugs and more.

What is Impaired gastric emptying?

Impaired gastric emptying is found to be associated with 1,476 drugs and 710 conditions by eHealthMe.

Number of Lovastatin and Impaired gastric emptying reports submitted per year:

Could Lovastatin cause Impaired gastric emptying?

Gender of people who have Impaired gastric emptying when taking Lovastatin *:

female: 76.67 %
male: 23.33 %

Age of people who have Impaired gastric emptying when taking Lovastatin *:

Common drugs people take besides Lovastatin *:

Common side effects people have besides Impaired gastric emptying *:

Fatigue (feeling of tiredness): 17 people, 54.84%
Nausea (feeling of having an urge to vomit): 16 people, 51.61%
Pain: 16 people, 51.61%
Stress And Anxiety: 15 people, 48.39%
Weakness: 13 people, 41.94%
Back Pain: 12 people, 38.71%
Cough: 12 people, 38.71%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 38.71%
Weight Decreased: 10 people, 32.26%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 10 people, 32.26%

Common conditions people have *:

Immunodeficiency Common Variable: 4 people, 12.90%
Type 2 Diabetes: 3 people, 9.68%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 9.68%
Cardiac Disorder: 3 people, 9.68%
Diabetes: 2 people, 6.45%
Sinusitis (inflammation of sinus): 2 people, 6.45%
Neoplasm Malignant (cancer tumour): 2 people, 6.45%
Immunodeficiency: 2 people, 6.45%
Birth Control: 1 person, 3.23%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Lovastatin and have Impaired gastric emptying?

Check whether Impaired gastric emptying is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Impaired gastric emptying and when was it recovered:

Impaired gastric emptying in Lovastatin

Expand to all the drugs that have ingredients of lovastatin:

Impaired gastric emptying and drugs with ingredients of lovastatin

Alternative drugs to, pros and cons of Lovastatin:

Lovastatin (31,004 reports)

Common Lovastatin side effects:

Fatigue (feeling of tiredness): 2,020 reports
Drug ineffective: 1,992 reports
Weakness: 1,652 reports
Dizziness: 1,584 reports
Breathing difficulty: 1,575 reports
Pain: 1,557 reports
Diarrhea: 1,521 reports

Browse all side effects of Lovastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Impaired gastric emptying treatments and more:

Impaired gastric emptying (10,417 reports)

COVID vaccines that are related to Impaired gastric emptying:

Common drugs associated with Impaired gastric emptying:

How the study uses the data?

The study uses data from the FDA. It is based on lovastatin (the active ingredients of Lovastatin) and Lovastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.